407 related articles for article (PubMed ID: 16453261)
1. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.
Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A;
J Infect Dis; 2006 Mar; 193(5):664-71. PubMed ID: 16453261
[TBL] [Abstract][Full Text] [Related]
2. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
[TBL] [Abstract][Full Text] [Related]
3. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
Andersson J
Scand J Infect Dis Suppl; 1996; 100():72-82. PubMed ID: 8860357
[TBL] [Abstract][Full Text] [Related]
4. Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters.
Nikoskelainen J; Ablashi DV; Isenberg RA; Neel EU; Miller RG; Stevens DA
J Immunol; 1978 Oct; 121(4):1239-44. PubMed ID: 81224
[TBL] [Abstract][Full Text] [Related]
5. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
6. IFN-gamma mediated pathways in patients with fatigue and chronic active Epstein Barr virus-infection.
Bellmann-Weiler R; Schroecksnadel K; Holzer C; Larcher C; Fuchs D; Weiss G
J Affect Disord; 2008 May; 108(1-2):171-6. PubMed ID: 17945348
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
8. Infectious mononucleosis, Epstein-Barr virus, and chronic fatigue syndrome: a prospective case series.
Fark AR
J Fam Pract; 1991 Feb; 32(2):202, 205-6, 209. PubMed ID: 1846641
[TBL] [Abstract][Full Text] [Related]
9. Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient.
Piriou ER; van Dort K; Weel JF; Bemelman FJ; Gamadia LE; van Oers MH; van Baarle D
Clin Immunol; 2006 Apr; 119(1):16-20. PubMed ID: 16386961
[TBL] [Abstract][Full Text] [Related]
10. Clinical manifestations and quantitative analysis of virus load in Taiwanese children with Epstein-Barr virus-associated infectious mononucleosis.
Cheng CC; Chang LY; Shao PL; Lee PI; Chen JM; Lu CY; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Jun; 40(3):216-21. PubMed ID: 17639161
[TBL] [Abstract][Full Text] [Related]
11. Antigen-driven expansion and contraction of CD8+-activated T cells in primary EBV infection.
Hoshino Y; Morishima T; Kimura H; Nishikawa K; Tsurumi T; Kuzushima K
J Immunol; 1999 Nov; 163(10):5735-40. PubMed ID: 10553106
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of Epstein-Barr virus load and virus-specific CD8+ T cells in acute infectious mononucleosis.
Hoshino Y; Nishikawa K; Ito Y; Kuzushima K; Kimura H
J Clin Virol; 2011 Mar; 50(3):244-6. PubMed ID: 21185773
[TBL] [Abstract][Full Text] [Related]
13. Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation.
Gotoh K; Ito Y; Shibata-Watanabe Y; Kawada J; Takahashi Y; Yagasaki H; Kojima S; Nishiyama Y; Kimura H
Clin Infect Dis; 2008 May; 46(10):1525-34. PubMed ID: 18419486
[TBL] [Abstract][Full Text] [Related]
14. A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis.
Crawford DH; Macsween KF; Higgins CD; Thomas R; McAulay K; Williams H; Harrison N; Reid S; Conacher M; Douglas J; Swerdlow AJ
Clin Infect Dis; 2006 Aug; 43(3):276-82. PubMed ID: 16804839
[TBL] [Abstract][Full Text] [Related]
15. Long-term shedding of infectious epstein-barr virus after infectious mononucleosis.
Fafi-Kremer S; Morand P; Brion JP; Pavese P; Baccard M; Germi R; Genoulaz O; Nicod S; Jolivet M; Ruigrok RW; Stahl JP; Seigneurin JM
J Infect Dis; 2005 Mar; 191(6):985-9. PubMed ID: 15717276
[TBL] [Abstract][Full Text] [Related]
16. Cytokine responses in a severe case of glandular fever treated successfully with foscarnet combined with prednisolone and intravenous immunoglobulin.
Ma C; Wong CK; Wong BC; Chan KC; Lun SW; Lee N; Wu J; Cockram CS; Chan PK; Tang JW
J Med Virol; 2009 Jan; 81(1):99-105. PubMed ID: 19031455
[TBL] [Abstract][Full Text] [Related]
17. CD4(+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remission.
Marshall NA; Culligan DJ; Johnston PW; Millar C; Barker RN; Vickers MA
Br J Haematol; 2007 Oct; 139(1):81-9. PubMed ID: 17854310
[TBL] [Abstract][Full Text] [Related]
18. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of infection with human herpesvirus-6 in EBV-negative infectious mononucleosis: data acquisition for computer modeling.
Krueger GR; Bertram G; Ramon A; Koch B; Ablashi DV; Brandt ME; Wang G; Buja LM
In Vivo; 2001; 15(5):373-80. PubMed ID: 11695232
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
Sugaya N; Kimura H; Hara S; Hoshino Y; Kojima S; Morishima T; Tsurumi T; Kuzushima K
J Infect Dis; 2004 Sep; 190(5):985-8. PubMed ID: 15295706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
